查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
吸入和鼻腔产品合同製造服务提供商的全球市场规模,份额和趋势分析：按药物输送产品（中剂量吸入器,粉末吸入器,雾化器）,服务,地区,分部预测2023-2030
市场调查报告书
商品编码
1170990

吸入和鼻腔产品合同製造服务提供商的全球市场规模,份额和趋势分析：按药物输送产品（中剂量吸入器,粉末吸入器,雾化器）,服务,地区,分部预测2023-2030

Inhaled And Intranasal Products Contract Service Providers Market Size, Share & Trends Analysis Report By Drug Delivery Product (Metered-dose inhalers, Dry powder inhalers, Nebulizers), By Services, By Region And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 275 Pages | 商品交期: 2-10个工作天内

价格

全球吸入器和鼻腔产品合同製造服务提供商市场规模预计到 2030 年将达到 45 亿美元，从 2023 年到 2030 年的复合年增长率为 8.5%。

由于开发和产品设计的进步以及越来越多的製造商致力于降低医疗设备的成本，药物输送系统的改进正在推动市场的增长。

本报告研究了全球吸入和鼻腔产品合同製造服务提供商市场，并提供了全面的信息，包括市场前景、市场分析和竞争格局。

内容

第一章调查方法及范围

  • 市场细分和范围
    • 给药产品
    • 服务
    • 区域范围
  • 调查方法
  • 信息采购
    • 购买的数据库
    • GVR 内部数据库
    • 次要信息
    • 初步调查
  • 信息或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 模型详细信息
    • 商品流分析（模型 1）
    • 批量价格分析（模型 2）
  • 二级信息列表
  • 主要信息列表
  • 目的

第 2 章执行摘要

  • 市场展望

第 3 章吸入和鼻腔产品合同製造服务提供商的市场变量、趋势和范围

  • 市场系列展望
    • 母公司的市场前景
    • 相关/补充市场展望
  • 市场动态
    • 市场驱动因素分析
      • COPD 等慢性病患病率上升，糖尿病患病率上升
      • 不断增长的老年人口
      • 增加产品供应的技术进步
    • 市场製约因素分析
      • 关于产品审批的严格政府规定
    • COVID-19 的影响和恢復分析
    • 热图分析
    • 对主要交易和战略联盟的分析
    • 行业分析 - 波特五力分析
    • PESTLE 分析

第 4 章吸入器和鼻腔合同製造服务提供商市场：给药产品细分分析

  • 吸入和鼻腔产品合同製造服务提供商市场：定义和范围
  • 吸入和鼻腔产品合同製造服务提供商市场：给药产品市场份额分析（2022 年和 2030 年）
    • 固定剂量吸入器
    • 粉末吸入器
    • 雾化器
    • 其他

第 5 章吸入器和鼻腔产品合同製造服务提供商市场：服务细分分析

  • 吸入和鼻腔产品合同製造服务提供商市场：定义和范围
  • 吸入和鼻腔产品合同製造服务提供商市场：服务市场份额分析（2022 年和 2030 年）
    • 质量保证
    • 监管服务
    • 产品设计和开发
    • 产品测试和灭菌
    • 产品实施
    • 产品升级
    • 产品维护
    • 合同製造

第 6 章吸入器和鼻腔合同製造服务提供商市场：区域分析

  • 吸入和鼻腔合同製造服务提供商：区域市场份额分析（2022 年和 2030 年）
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 意大利
    • 西班牙
    • 丹麦
      • 丹麦吸入和鼻腔合同製造服务提供商市场（百万美元）（2018-2030 年）
    • 瑞典
      • 瑞典吸入和鼻腔合同製造服务提供商市场（百万美元）（2018-2030 年）
    • 挪威
      • 挪威吸入和鼻腔合同製造服务提供商市场（百万美元）（2018-2030 年）
    • 其他欧盟
      • 其他欧盟吸入和鼻腔合同製造服务提供商市场（百万美元）（2018-2030 年）
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 泰国
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 中东和非洲
    • 南非
    • 南阿拉伯
    • 阿拉伯联合酋长国
    • 科威特
    • 其他中东和非洲地区

第七章竞争格局

  • 吸入和鼻腔合同製造服务提供商：公司市场份额分析（2022 年和 2030 年）
  • 公司简介
    • Lonza
    • Catalent
    • Kindeva Drug Delivery（旧3M Drug Delivery Systems）
    • Recipharma
    • Quotient Services
    • Hovione
    • Colep
    • Beximo Pharmaceuticals
    • DPT Laboratories
    • Orion
Product Code: GVR-4-68040-001-3

Inhaled And Intranasal Products Contract Service Providers Market Growth & Trends:

The global inhaled and intranasal products contract service providers market size is estimated to reach USD 4.5 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 8.5% from 2023 to 2030. There is an increased awareness of the effective and advanced respiratory devices compared to the traditional treatments fueling the growth of the market.

Inhaler design has seen little change in the past ten years, but some features have led to advancements that open new possibilities for disease treatment according to an article published by the National Library of Medicine (NIH) in 2021. The development of vibrating mesh systems for nebulizers was the most significant advancement, whereas the formulation, metering system, and aerosol dispersion properties are the three main components of dry powder inhaler technology. Furthermore, one of the most important breakthroughs at the start of the new millennium was the regulatory approval and commercialization of Advair/Seretide (GlaxoSmithKline). These developments and advancements in the design of the product improve the drug delivery system. Hence, contributing to the growth of the inhaled & intranasal products contract service providers market.

COVID-19 has resulted in a positive impact on the market. For instance, according to a July 2020 article titled "Inhalers Safe During COVID-19 Pandemic," asthma and chronic obstructive pulmonary disease patients are usually prescribed inhaled and oral corticosteroids along with inhalers to avoid attacks. Inhaler shortages occurred in the U.K. as a result of a 400% increase in demand during the pandemic. The U.K.'s population was attempting to stock up in anticipation of the COVID-19 pandemic, according to the Department of Health and Social Care, which resulted in distressing shortages. As a result, during the pandemic phase, such incidences increased the demand for the market.

Inhaled And Intranasal Products Contract Service Providers Market Report Highlights:

  • Metered- dose inhalers (MDIs) segment dominated the market with a revenue share of 50.6% in 2022. This is due to the rise in their ease of use, which is often self-administered by the patient through inhalation in short bursts of a predetermined dose
  • Based on services, contract manufacturing dominated the segment with a revenue share of 54.8% in 2022. The increasing focus of manufacturers on reducing the cost of medical devices drives the growth of the market
  • Quality assurance services is anticipated to register the fastest CAGR growth of 10.8% during the forecast period
  • Asia Pacific dominated the market in 2022 with a 41.7% market share. The presence of a large number of contract manufacturers, and increasing respiratory diseases such as COPD are the key factors driving the growth of the market

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Drug Delivery Product
    • 1.1.2. Services
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Volume price analysis (Model 2)
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2
    • 1.9.3. Objective 3
    • 1.9.4. Objective 4

Chapter 2. Executive Summary

  • 2.1. Market Outlook

Chapter 3. Inhaled and Intranasal Products Contract Service Providers Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of chronic diseases such as COPD, increasing prevalence of diabetes
      • 3.2.1.2. Rise in geriatric population
      • 3.2.1.3. Increase in technological advancement w.r.t to product offerings
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Stringent Government Regulations for the Product Approval
    • 3.2.3. Covid-19 Impact & Recovery Analysis
    • 3.2.4. Heat Map Analysis
    • 3.2.5. Major Deals and Strategic Alliances Analysis
    • 3.2.6. Industry Analysis - Porter's
    • 3.2.7. PESTLE Analysis

Chapter 4. Inhaled and Intranasal Products Contract Service Providers Market: Drug Delivery Product Segment Analysis

  • 4.1. Inhaled and Intranasal Products Contract Service Providers Market: Definition & Scope
  • 4.2. Inhaled and Intranasal Products Contract Service Providers Market: Drug Delivery Product Market Share Analysis, 2022 & 2030
    • 4.2.1. Metered- dose Inhalers
      • 4.2.1.1. Metered- dose Inhalers Market, 2018 - 2030 (USD Million)
    • 4.2.2. Dry Powder Inhalers
      • 4.2.2.1. Dry Powder Inhalers Market, 2018 - 2030 (USD Million)
    • 4.2.3. Nebulizers
      • 4.2.3.1. Nebulizers Market, 2018 - 2030 (USD Million)
    • 4.2.4. Others
      • 4.2.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Inhaled and Intranasal Products Contract Service Providers Market: Services Segment Analysis

  • 5.1. Inhaled and Intranasal Products Contract Service Providers Market: Definition & Scope
  • 5.2. Inhaled and Intranasal Products Contract Service Providers Market: Services Market Share Analysis, 2022 & 2030
    • 5.2.1. Quality Assurance
      • 5.2.1.1. Quality Assurance Market, 2018 - 2030 (USD Million)
    • 5.2.2. Regulatory Affairs Services
      • 5.2.2.1. Regulatory Affairs Services Market, 2018 - 2030 (USD Million)
    • 5.2.3. Product Design & Development
      • 5.2.3.1. Product Design & Development Market, 2018 - 2030 (USD Million)
    • 5.2.4. Product Testing & Sterilization
      • 5.2.4.1. Product Testing & Sterilization Market, 2018 - 2030 (USD Million)
    • 5.2.5. Product Implementation
      • 5.2.5.1. Product Implementation Market, 2018 - 2030 (USD Million)
    • 5.2.6. Product Upgrade
      • 5.2.6.1. Product Upgrade Market, 2018 - 2030 (USD Million)
    • 5.2.7. Product Maintenance
      • 5.2.7.1. Product Maintenance Market, 2018 - 2030 (USD Million)
    • 5.2.8. Contract Manufacturing
      • 5.2.8.1. Contract Manufacturing Market, 2018 - 2030 (USD Million)

Chapter 6. Inhaled and Intranasal Products Contract Service Providers Market: Regional Analysis

  • 6.1. Inhaled and Intranasal Products Contract Service Providers: Regional market share analysis, 2022 & 2030
  • 6.2. North America
    • 6.2.1. North America Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.3.2. U.K.
      • 6.3.2.1. U.K. Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.3.4. Italy
      • 6.3.4.1. Italy Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.3.5. Spain
      • 6.3.5.1. Spain Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.3.6. Denmark
      • 6.3.6.1. Denmark Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030(USD Million)
    • 6.3.7. Sweden
      • 6.3.7.1. Sweden Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030(USD Million)
    • 6.3.8. Norway
      • 6.3.8.1. Norway Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030(USD Million)
    • 6.3.9. Rest of EU
      • 6.3.9.1. Rest of EU Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030(USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.4.2. China
      • 6.4.2.1. China Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.4.3. India
      • 6.4.3.1. India Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.4.4. Japan
      • 6.4.4.1. Japan Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Australia Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.4.6. Thailand
      • 6.4.6.1. Thailand Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.4.7. South Korea
      • 6.4.7.1. South Korea Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.4.8. Rest of APAC
      • 6.4.8.1. Rest of APAC Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.5.3. Mexico
      • 6.5.3.1. Mexico Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.5.4. Argentina
      • 6.5.4.1. Argentina Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.5.5. Rest of LATAM
      • 6.5.5.1. Rest of LATAM Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
  • 6.6. MEA
    • 6.6.1. MEA Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.6.3. South Arabia
      • 6.6.3.1. South Africa Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)
    • 6.6.6. Rest of MEA
      • 6.6.6.1. Rest of MEA Inhaled and Intranasal Products Contract Service Providers Market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Inhaled and Intranasal Products Contract Service Providers: Company market share analysis, 2022 & 2030
  • 7.2. Company Profiles
    • 7.2.1. Lonza
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Service benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Catalent
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Service benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Kindeva Drug Delivery (Formerly 3M Drug Delivery Systems)
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Service benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Recipharma
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Service benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Quotient Services
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Service benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Hovione
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Service benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Colep
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Service benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Beximo Pharmaceuticals
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Service benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. DPT Laboratories
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Service benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. Orion
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Service benchmarking
      • 7.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary sources
  • Table 2 List of Abbreviations

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Volume price analysis
  • Fig. 9 Inhaled and Intranasal products contract service providers market snapshot (2022)
  • Fig. 10 Inhaled and Intranasal products contract service providers market segmentation
  • Fig. 11 Heat map analysis
  • Fig. 12 Parent market outlook
  • Fig. 13 Ancillary market outlook
  • Fig. 14 Penetration & growth prospect mapping
  • Fig. 15 Market driver relevance analysis (Current & future impact)
  • Fig. 16 Market restraint relevance analysis (Current & future impact)
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 19 Inhaled and Intranasal Products Contract Service Providers market drug delivery product outlook: Segment dashboard
  • Fig. 20 Inhaled and Intranasal Products Contract Service Providers market: drug delivery product movement analysis
  • Fig. 21 Metered- dose inhalers market, 2018 - 2030 (USD Million)
  • Fig. 22 Dry powder inhalers market, 2018 - 2030 (USD Million)
  • Fig. 23 Nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 24 Others market, 2018 - 2030 (USD Million)
  • Fig. 25 Inhaled and Intranasal Products Contract Service Providers market services outlook: Segment dashboard
  • Fig. 26 Inhaled and Intranasal Products Contract Service Providers market: services movement analysis
  • Fig. 27 Quality Assurance market, 2018 - 2030 (USD Million)
  • Fig. 28 Regulatory Affair Services market, 2018 - 2030 (USD Million)
  • Fig. 29 Product Design & Development market, 2018 - 2030 (USD Million)
  • Fig. 30 Product Testing & Sterilization market, 2018 - 2030 (USD Million)
  • Fig. 31 Product Implementation market, 2018 - 2030 (USD Million)
  • Fig. 32 Product Upgrade market, 2018 - 2030 (USD Million)
  • Fig. 33 Product Maintenance market, 2018 - 2030 (USD Million)
  • Fig. 34 Contract Manufacturing market, 2018 - 2030 (USD Million)
  • Fig. 35 Regional market: Key takeaways
  • Fig. 36 Inhaled and Intranasal Products Contract Service Providers market: Regional movement analysis
  • Fig. 37 North America. market, 2018 - 2030 (USD Million)
  • Fig. 38 U.S. market, 2018 - 2030 (USD Million)
  • Fig. 39 Canada market, 2018 - 2030 (USD Million)
  • Fig. 40 Europe market, 2018 - 2030 (USD Million)
  • Fig. 41 U.K. market, 2018 - 2030 (USD Million)
  • Fig. 42 Germany market, 2018 - 2030 (USD Million)
  • Fig. 43 France market, 2018 - 2030 (USD Million)
  • Fig. 44 Italy market, 2018 - 2030 (USD Million)
  • Fig. 45 Spain market, 2018 - 2030 (USD Million)
  • Fig. 46 Denmark market, 2018 - 2030 (USD Million)
  • Fig. 47 Sweden market, 2018 - 2030 (USD Million)
  • Fig. 48 Norway market, 2018 - 2030 (USD Million)
  • Fig. 49 Rest of EU market, 2018 - 2030 (USD Million)
  • Fig. 50 Asia Pacific market, 2018 - 2030 (USD Million)
  • Fig. 51 Japan market, 2018 - 2030 (USD Million)
  • Fig. 52 China market, 2018 - 2030 (USD Million)
  • Fig. 53 India market, 2018 - 2030 (USD Million)
  • Fig. 54 Australia market, 2018 - 2030 (USD Million)
  • Fig. 55 Thailand market, 2018 - 2030 (USD Million)
  • Fig. 56 South Korea market, 2018 - 2030 (USD Million)
  • Fig. 57 Rest of APAC market, 2018 - 2030 (USD Million)
  • Fig. 58 Latin America market, 2018 - 2030 (USD Million)
  • Fig. 59 Brazil market, 2018 - 2030 (USD Million)
  • Fig. 60 Mexico market, 2018 - 2030 (USD Million)
  • Fig. 61 Argentina market, 2018 - 2030 (USD Million)
  • Fig. 62 Rest of LATAM market, 2018 - 2030 (USD Million)
  • Fig. 63 MEA market, 2018 - 2030 (USD Million)
  • Fig. 64 South Africa market, 2018 - 2030 (USD Million)
  • Fig. 65 Saudi Arabia market, 2018 - 2030 (USD Million)
  • Fig. 66 UAE market, 2018 - 2030 (USD Million)
  • Fig. 67 Kuwait market, 2018 - 2030 (USD Million)
  • Fig. 68 Rest of MEA market, 2018 - 2030 (USD Million)